Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | yes | yes: 25 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 6 |
NetGPI | no | yes: 0, no: 6 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000781 | chromosome, telomeric region | 3 | 1 |
GO:0005634 | nucleus | 5 | 5 |
GO:0005654 | nucleoplasm | 2 | 1 |
GO:0005662 | DNA replication factor A complex | 3 | 1 |
GO:0032991 | protein-containing complex | 1 | 1 |
GO:0035861 | site of double-strand break | 3 | 1 |
GO:0043226 | organelle | 2 | 5 |
GO:0043227 | membrane-bounded organelle | 3 | 5 |
GO:0043229 | intracellular organelle | 3 | 5 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 5 |
GO:0090734 | site of DNA damage | 2 | 1 |
GO:0098687 | chromosomal region | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 5 |
GO:0140513 | nuclear protein-containing complex | 2 | 1 |
Related structures:
AlphaFold database: A4H800
Term | Name | Level | Count |
---|---|---|---|
GO:0000724 | double-strand break repair via homologous recombination | 7 | 1 |
GO:0000725 | recombinational repair | 6 | 1 |
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 5 |
GO:0006259 | DNA metabolic process | 4 | 5 |
GO:0006260 | DNA replication | 5 | 5 |
GO:0006281 | DNA repair | 5 | 5 |
GO:0006289 | nucleotide-excision repair | 6 | 1 |
GO:0006302 | double-strand break repair | 6 | 1 |
GO:0006310 | DNA recombination | 5 | 5 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 5 |
GO:0006807 | nitrogen compound metabolic process | 2 | 5 |
GO:0006950 | response to stress | 2 | 5 |
GO:0006974 | DNA damage response | 4 | 5 |
GO:0008152 | metabolic process | 1 | 5 |
GO:0009987 | cellular process | 1 | 5 |
GO:0033554 | cellular response to stress | 3 | 5 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 5 |
GO:0043170 | macromolecule metabolic process | 3 | 5 |
GO:0044237 | cellular metabolic process | 2 | 5 |
GO:0044238 | primary metabolic process | 2 | 5 |
GO:0044260 | obsolete cellular macromolecule metabolic process | 3 | 5 |
GO:0046483 | heterocycle metabolic process | 3 | 5 |
GO:0050896 | response to stimulus | 1 | 5 |
GO:0051716 | cellular response to stimulus | 2 | 5 |
GO:0071704 | organic substance metabolic process | 2 | 5 |
GO:0090304 | nucleic acid metabolic process | 4 | 5 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 5 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 7 |
GO:0005488 | binding | 1 | 7 |
GO:0097159 | organic cyclic compound binding | 2 | 7 |
GO:1901363 | heterocyclic compound binding | 2 | 7 |
GO:0003677 | DNA binding | 4 | 5 |
GO:0003697 | single-stranded DNA binding | 5 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 66 | 70 | PF00656 | 0.562 |
CLV_PCSK_KEX2_1 | 92 | 94 | PF00082 | 0.386 |
CLV_PCSK_PC1ET2_1 | 92 | 94 | PF00082 | 0.436 |
CLV_PCSK_SKI1_1 | 120 | 124 | PF00082 | 0.436 |
DOC_CKS1_1 | 55 | 60 | PF01111 | 0.560 |
DOC_USP7_MATH_1 | 139 | 143 | PF00917 | 0.436 |
DOC_WW_Pin1_4 | 54 | 59 | PF00397 | 0.560 |
LIG_14-3-3_CanoR_1 | 152 | 160 | PF00244 | 0.436 |
LIG_14-3-3_CanoR_1 | 16 | 24 | PF00244 | 0.570 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.518 |
LIG_FHA_1 | 122 | 128 | PF00498 | 0.436 |
LIG_FHA_1 | 19 | 25 | PF00498 | 0.540 |
LIG_FHA_1 | 48 | 54 | PF00498 | 0.570 |
LIG_FHA_1 | 55 | 61 | PF00498 | 0.570 |
LIG_FHA_2 | 154 | 160 | PF00498 | 0.436 |
LIG_LIR_Gen_1 | 72 | 82 | PF02991 | 0.542 |
LIG_LIR_LC3C_4 | 21 | 26 | PF02991 | 0.570 |
LIG_LIR_Nem_3 | 72 | 78 | PF02991 | 0.545 |
LIG_NRBOX | 122 | 128 | PF00104 | 0.436 |
LIG_PDZ_Class_2 | 178 | 183 | PF00595 | 0.571 |
LIG_SH3_3 | 32 | 38 | PF00018 | 0.462 |
LIG_WRC_WIRS_1 | 127 | 132 | PF05994 | 0.436 |
MOD_CK1_1 | 97 | 103 | PF00069 | 0.448 |
MOD_CK2_1 | 139 | 145 | PF00069 | 0.436 |
MOD_GlcNHglycan | 105 | 108 | PF01048 | 0.444 |
MOD_GlcNHglycan | 135 | 138 | PF01048 | 0.500 |
MOD_GlcNHglycan | 2 | 5 | PF01048 | 0.627 |
MOD_GlcNHglycan | 47 | 50 | PF01048 | 0.370 |
MOD_GlcNHglycan | 96 | 99 | PF01048 | 0.440 |
MOD_GSK3_1 | 159 | 166 | PF00069 | 0.436 |
MOD_GSK3_1 | 54 | 61 | PF00069 | 0.592 |
MOD_GSK3_1 | 63 | 70 | PF00069 | 0.635 |
MOD_GSK3_1 | 97 | 104 | PF00069 | 0.374 |
MOD_NEK2_1 | 126 | 131 | PF00069 | 0.436 |
MOD_NEK2_1 | 85 | 90 | PF00069 | 0.436 |
MOD_PIKK_1 | 85 | 91 | PF00454 | 0.436 |
MOD_PKA_2 | 15 | 21 | PF00069 | 0.570 |
MOD_PKA_2 | 151 | 157 | PF00069 | 0.314 |
MOD_PKA_2 | 45 | 51 | PF00069 | 0.570 |
MOD_PKA_2 | 85 | 91 | PF00069 | 0.436 |
MOD_Plk_1 | 144 | 150 | PF00069 | 0.347 |
MOD_Plk_4 | 126 | 132 | PF00069 | 0.436 |
MOD_Plk_4 | 60 | 66 | PF00069 | 0.570 |
MOD_ProDKin_1 | 54 | 60 | PF00069 | 0.560 |
TRG_ENDOCYTIC_2 | 75 | 78 | PF00928 | 0.551 |
TRG_Pf-PMV_PEXEL_1 | 165 | 170 | PF00026 | 0.377 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I2B8 | Leptomonas seymouri | 90% | 72% |
A0A0S4JPP2 | Bodo saltans | 33% | 100% |
A0A1X0NTN7 | Trypanosomatidae | 61% | 71% |
A0A3Q8IDB6 | Leishmania donovani | 92% | 71% |
A0A3S5IRR4 | Trypanosoma rangeli | 61% | 68% |
A4HWC8 | Leishmania infantum | 92% | 71% |
C9ZNX0 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 56% | 100% |
E9AQ28 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 93% | 71% |
Q23697 | Crithidia fasciculata | 90% | 71% |
Q4QFF3 | Leishmania major | 92% | 100% |
Q5RC43 | Pongo abelii | 26% | 68% |